Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype.

about

The Role of Liver-Directed Therapy in Metastatic Colorectal Cancer

P2860

Q57193222-DAC1E1C8-50D0-4C38-B6C7-27A887C01DE0

P2860

Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype.

Item

http://www.wikidata.org/entity/Q49716871

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Phase II Study of Proton-Based ...... Importance of Tumor Genotype.

@en

Phase II Study of Proton-Based ...... Importance of Tumor Genotype.

@nl

type

Item

label

Phase II Study of Proton-Based ...... Importance of Tumor Genotype.

@en

Phase II Study of Proton-Based ...... Importance of Tumor Genotype.

@nl

prefLabel

Phase II Study of Proton-Based ...... Importance of Tumor Genotype.

@en

Phase II Study of Proton-Based ...... Importance of Tumor Genotype.

@nl

P1476

Phase II Study of Proton-Based ...... Importance of Tumor Genotype.

@en

P2093

A John Iafrate

http://www.w3.org/2001/XMLSchema#string

Andrew X Zhu

http://www.w3.org/2001/XMLSchema#string

Beow Y Yeap

http://www.w3.org/2001/XMLSchema#string

Cristina R Ferrone

http://www.w3.org/2001/XMLSchema#string

Darrell R Borger

http://www.w3.org/2001/XMLSchema#string

David P Ryan

http://www.w3.org/2001/XMLSchema#string

Erin I McDonnell

http://www.w3.org/2001/XMLSchema#string

Eunice L Kwak

http://www.w3.org/2001/XMLSchema#string

Harvey J Mamon

http://www.w3.org/2001/XMLSchema#string

Henning Willers

http://www.w3.org/2001/XMLSchema#string

P2860

Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities.

TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence.

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study.

Phase I study of individualized stereotactic body radiotherapy of liver metastases.

EGFR-mediated chromatin condensation protects KRAS-mutant cancer cells against ionizing radiation.

Comparative analysis of radiosensitizers for K-RAS mutant rectal cancers

A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors.

Mutational and clinical predictors of pathologic complete response in the treatment of locally advanced rectal cancer.

Outcomes by tumor histology and KRAS mutation status after lung stereotactic body radiation therapy for early-stage non-small-cell lung cancer.

P31

scholarly article

P356

10.1093/JNCI/DJX031

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28954285

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype.

about

P2860

P2860

Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P577

P698

P921